0001628280-25-047117
SEC filingRevenue declined 5.6% YoY with gross margin compression; goodwill impairment drove operating loss.
For the three months ended September 26, 2025, total revenues declined 5.6% to $510.0 million compared to $540.4 million in the prior year period, driven by a 7.1% drop in Products revenue to $445.0 million, partially offset by a 5.9% increase in Services revenue to $65.0 million. The Products decrease reflected a temporary slowdown in customer purchasing activity due to short-term market conditions. Gross profit fell 12.0% to $82.2 million, with gross margin contracting by 120 basis points to 16.1% from 17.3%, primarily due to higher employee restructuring-related costs, increased tariffs and duties, and unfavorable product mix. Operating profit declined sharply by 57.9% to $10.6 million, yielding an operating margin of 2.1% versus 4.7% in the prior year. The decline was attributed to higher employee-related expenses including severance costs from involuntary separations and a voluntary retirement program, along with tariff and duty increases.
Products segment revenue decreased 7.1% year-over-year, with gross margin declining from 15.8% to 14.5% and operating margin dropping from 4.7% to 1.8%. The margin pressures stemmed from higher restructuring costs, duties, and tariffs. Services segment revenue grew 5.9% on higher customer demand, but gross margin fell from 28.8% to 27.1% and operating margin slipped from 4.6% to 4.2%, driven by increased labor and compensation costs at a specific location. The international revenue mix continued to rise, now 76.4% of total revenue compared to 73.1% a year ago, as U.S. revenue declined due to a shift of product shipments overseas.
Management highlighted ongoing restructuring activities including involuntary separations and a voluntary retirement program as part of cost rationalization. No specific forward guidance was provided. The company expressed confidence in long-term semiconductor industry growth driven by AI, ML, and new process architectures, and noted increasing reliance by OEMs on partners like UCT. Capital expenditures for the remainder of 2025 are expected to be funded from operations and cash on hand. The company believes its existing cash ($314.1 million) and operating cash flow are sufficient for at least the next twelve months. Key risks include cyclical demand, tariff impacts, and the need to maintain financial covenants under the credit facility.
Cash and cash equivalents stood at $314.1M as of September 26, 2025, essentially flat from $313.9M at year-end 2024. Total debt net of issuance costs was $476.4M (gross $481.5M), consisting of $9.9M current and $466.5M non-current bank borrowings. The company had $146.6M available under its $150M revolver, plus $5.0M and €6.4M available in Israel and Czechia, respectively. Shareholders' equity attributable to UCT was $709.9M, down from $873.6M due to the $177.9M net loss and share repurchases.
No material purchase commitments were disclosed in the Notes. The company has operating lease obligations (not detailed here) and pension obligations with total estimated future payments of $20.2M over the next five years and thereafter. The underfunded pension liability was $2.7M as of September 26, 2025.
During the nine months ended September 26, 2025, the company repurchased 0.2 million shares for $3.4M under a $150M authorization. Subsequent to quarter end, on October 23, 2025, the Board approved a new $150M three-year buyback program. No dividends were paid on common stock; a small dividend of $0.1M was paid to a joint venture shareholder. Debt principal payments totaled $18.2M. Capital expenditures were $40.2M (2.6% of sales), allocated $26.4M to Products and $13.8M to Services.
For the nine months ended September 26, 2025, Products segment revenue was $1,356.9M (up 0.5% YoY) with a segment operating loss of $52.8M, impacted by a $77.6M goodwill impairment. Services segment revenue was $190.4M (up 3.4%) with an operating loss of $65.5M including a $73.5M impairment. Gross margins were 14.2% for Products and 27.6% for Services. Geographically, Singapore contributed 36.4% of total revenue, followed by the United States (24.4%) and Austria (10.2%). Customer concentration is high: Lam Research (36.0%) and Applied Materials (22.2%) represented 58.2% of revenue. Total segment assets declined to $1,720.5M from $1,919.9M, primarily due to goodwill impairment.
Despite a net loss of $171.0M, operating cash flow was a healthy $57.5M, driven by sizable non-cash charges including a $151.1M goodwill impairment, $56.7M in depreciation and amortization, and $14.4M stock-based compensation. Working capital provided a net $3.2M inflow, led by a $41.6M decrease in receivables, partially offset by a $22.8M decline in payables and a $12.1M income tax payable reduction.
Capital expenditures were $40.2M, down from $46.2M in the prior year. Free cash flow (computed as CFO less capex) was $17.3M, though not explicitly reported. Financing activities used $22.3M, including $18.2M in principal payments, $3.4M in share repurchases, and $0.1M in dividends. The company also had $59.3M in proceeds and extinguishment of bank borrowings (net zero), indicating balanced debt management.
The goodwill impairment ($151.1M) was a one-time non-cash charge that largely caused the net loss. Income taxes paid of $35.2M were significantly higher than the income tax payable change, indicating a large cash tax outlay. The positive effect of exchange rates on cash was $2.0M.